Neuropathy Is Not Associated With Clinical Outcomes in Patients Receiving Adjuvant Taxane-Containing Therapy for Operable Breast Cancer

作者: Bryan P. Schneider , Fengmin Zhao , Molin Wang , Vered Stearns , Silvana Martino

DOI: 10.1200/JCO.2011.39.8446

关键词:

摘要: Purpose Neuropathy is a common and potentially disabling complication of adjuvant taxane therapy. Recent studies have identified candidate single nucleotide polymorphisms associated with taxane-induced neuropathy. Therefore, we sought to determine whether neuropathy was breast cancer recurrence in clinical trial population who received Patients Methods Trial E1199 included 4,554 eligible women operable up four cycles doxorubicin cyclophosphamide every 3 weeks followed by paclitaxel 175 mg/m2 for (P3), 80 weekly 12 (P1), docetaxel 100 (D3), or 35 (D1). A Cox proportional hazards model used the relationship between disease-free survival (DFS), overall (OS), recurrence-free (RFS) treating status as time dependent covariate ...

参考文章(31)
Sandra M Swain, Joseph C Arezzo, Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and management. Clinical advances in hematology & oncology. ,vol. 6, pp. 455- 467 ,(2008)
E K Rowinsky, R C Donehower, V Chaudhry, D R Cornblath, Neurotoxicity of Taxol. Journal of The National Cancer Institute Monographs. ,vol. 1993, pp. 107- 115 ,(1993)
Wallace Akerley, James E. Herndon, Merrill J. Egorin, Alan P. Lyss, Hedy L. Kindler, Dianne M. Savarese, Carol A. Sherman, D. Marc Rosen, Donna Hollis, Mark J. Ratain, Mark R. Green, Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B. Cancer. ,vol. 97, pp. 2480- 2486 ,(2003) , 10.1002/CNCR.11375
Elke Persohn, Annalisa Canta, S. Schoepfer, Martin Traebert, Lutz Mueller, Alessandra Gilardini, Stefania Galbiati, Gabriella Nicolini, Arianna Scuteri, Francesca Lanzani, Giuditta Giussani, Guido Cavaletti, Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats. European Journal of Cancer. ,vol. 41, pp. 1460- 1466 ,(2005) , 10.1016/J.EJCA.2005.04.006
Emilio Bria, Cecilia Nistico, Federica Cuppone, Paolo Carlini, Mariangela Ciccarese, Michele Milella, Guido Natoli, Edmondo Terzoli, Francesco Cognetti, Diana Giannarelli, Benefit of taxanes as adjuvant chemotherapy for early breast cancer Cancer. ,vol. 106, pp. 2337- 2344 ,(2006) , 10.1002/CNCR.21886
Cedric S. Raine, Matias Röytta, Matthew Dolich, Microtubule-mitochondrial associations in regenerating axons after taxol intoxication Journal of Neurocytology. ,vol. 16, pp. 461- 468 ,(1987) , 10.1007/BF01668500
Janet Fricker, San Antonio Breast Cancer Symposium. Lancet Oncology. ,vol. 10, pp. 20- ,(2009) , 10.1016/S1470-2045(08)70329-2
A. Moreno-Aspitia, A. Dueck, T. Patel, D. Hillman, K. Tenner, S. Dakhil, K. Rowland, S. McLaughlin, E. Perez, , Paclitaxel-Related Peripheral Neuropathy Associated with Improved Outcome of Patients with Early Stage HER2+ Breast Cancer Who Did Not Receive Trastuzumab in the N9831 Clinical Trial. Cancer Research. ,vol. 69, pp. 2100- 2100 ,(2009) , 10.1158/0008-5472.SABCS-09-2100
Juan Miguel Jimenez-Andrade, Christopher M. Peters, Nicole A. Mejia, Joseph R. Ghilardi, Michael A. Kuskowski, Patrick W. Mantyh, Sensory neurons and their supporting cells located in the trigeminal, thoracic and lumbar ganglia differentially express markers of injury following intravenous administration of paclitaxel in the rat. Neuroscience Letters. ,vol. 405, pp. 62- 67 ,(2006) , 10.1016/J.NEULET.2006.06.043